FREE CONSULT
1300 633 226
Home
New Patients
Why Cannvalate?
Free Consult
Download Guide
Patient FAQs
Existing Patients
Order Repeat
Premium Care Plans
Patient FAQs
Patient Resources
Anxiety
Chronic Pain
Fibromyalgia
IBD
Insomnia
Migraine
Doctors
Become A Prescriber
Refer Your Patients
Clinical Research
Media
Contact
Media
Home
Media
Media Releases
Category:
Media Releases
Media Releases
25 Sep, 2019
Cannvalate secure Cannabinoid Research Deal with Professor Raphael Mechoulam’s Israel-based company Cannbit
Media Releases
26 Jul, 2019
Cannvalate CEO Dr Sud Agarwal joins Impression Healthcare medical advisory board
Media Releases
16 May, 2019
Cannvalate continues international expansion with appointment of new Executive Director of Global Business
Media Releases
07 May, 2019
Cannvalate signs distribution and logistics deal with MGC Pharma (ASX:MXC)
Media Releases
02 Apr, 2019
Cannvalate appoints first international employee as part of global expansion strategy
Media Releases
02 Apr, 2019
Australia’s first medically backed cannabis company completes $4million Series A round
Media Releases
24 Mar, 2019
Cannvalate Signs Deal with Althea to Increase Patient Access to Medicinal Cannabis in Australia
Media Releases
21 Mar, 2019
Cannvalate partners with Impression Healthcare (ASX:IHL) to deliver four medicinal cannabis clinical trials valued at over $3million
Download Your Free Guide
Discover common applications and discover if treatment is for you.
Privacy Policy:
Your Information is 100% Secure.
×